Part Used : ไม่ระบุ
Activity : P-GLYCOPROTEIN INHIBITION
Solvent/Active Compound : highly oxygenated lanostane derivatives
Type of experiment : in vitro
Type of animal : -
N(Total) : -
N(Treatment) : -
Route : -
Dose/Conc.(herb) : 20 micromolar
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Remark : Type of experiment: human breast adenocarcinoma cell line (MCF-7) and adriamycin-resistant MCF-7 (MCF-7/ADR) cells
Note : Ganoderlactone A, Ganoderlactone E, 11Beta-hydroxy-3,7-dioxo-5alpha-lanosta-8,24(E)-dien-26-oic acid and methyl lucidenate F had significant inhibitory effects on P-glycoprotein.